Please login to the form below

Not currently logged in
Email:
Password:

F-star appoints vice president of protein sciences

Mike Davies joins from CPI Biologics

F-star Mike DaviesVienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site.

Davies has over 15 years of experience the development, manufacture and commercialisation of recombinant protein therapeutics and joins F-star from CPI Biologics where he has served as head of analytical strategy, biologics since April 2014.

Prior to this, Davies worked at Swiss pharma supplier Lonza, which he joined as a scientist in 1997 and held several senior leadership roles in analytical strategy and development before being promoted to analytical services head in 2009.

John Haurum, chief executive officer of F-star, said: “We are pleased to welcome Mike to the team and look forward to working with him.

“His strong experience in the development and commercialisation of recombinant protein therapeutics will further enable us to progress our immune-oncology pipeline into the clinic.”

23rd March 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics